Finance

Lists
OBAT:IDX
Brigit Biofarmaka Teknologi Tbk PT
246,00 IDR
0,00%
(0,00) 1D
12-ноя., 16:00:04 GMT+7  ·   IDR
All symbols
SymbolPriceChange% Change
Generating top insights for OBAT...
Open
246 IDR
High
248 IDR
Low
236 IDR
Mkt. cap
167,37 млд
Avg. vol.
500,31 миң
Volume
0,00
Dividend
3,07%
Quarterly dividend
2 IDR
Ex-dividend date
2026-ж., 22-май
P/E ratio
8,65
52-wk high
440 IDR
52-wk low
190 IDR
EPS
28 IDR
Shares outstanding
680,38 млн
No. of employees
240
Open
246 IDR
High
248 IDR
Low
236 IDR
Mkt. cap
167,37 млд
Avg. vol.
500,31 миң
Volume
0,00
Dividend
3,07%
Quarterly dividend
2 IDR
Ex-dividend date
2026-ж., 22-май
P/E ratio
8,65
52-wk high
440 IDR
52-wk low
190 IDR
EPS
28 IDR
Shares outstanding
680,38 млн
No. of employees
240
News stories
From web sources and news partners
About Brigit Biofarmaka Teknologi Tbk PT
CEO-
Employees240
Founded2015
Headquarters-
SectorConsumer Staples
IndustryPersonal care products
Previous reportsAll values in IDR
Loading Previous Earnings...
Revenue
Net income
All values in IDR
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
38,18 млд
45,37 млд
43,82 млд
45,18 млд
Cost of goods sold
18,76 млд
35,71 млд
28,17 млд
28,27 млд
Cost of revenue
18,76 млд
35,71 млд
28,17 млд
28,27 млд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7,92 млд
6,42 млд
10,53 млд
10,81 млд
Operating expense
8,67 млд
7,08 млд
10,83 млд
10,70 млд
Total operating expenses
27,43 млд
42,80 млд
39,00 млд
38,97 млд
Operating income
10,75 млд
2,57 млд
4,83 млд
6,21 млд
Other non operating income
-54,54 млн
165,04 млн
242,73 млн
-92,66 млн
EBT including unusual items
10,67 млд
3,27 млд
4,87 млд
5,83 млд
EBT excluding unusual items
10,69 млд
3,25 млд
4,87 млд
5,83 млд
Income tax expense
4,46 млд
2,80 млд
-
1,39 млд
Effective tax rate
41,86%
85,71%
-
23,88%
Other operating expenses
751,69 млн
660,16 млн
296,55 млн
-105,38 млн
Net income
2,38 млд
2,47 млд
2,92 млд
4,40 млд
Net profit margin
6,22%
5,44%
6,65%
9,75%
Earnings per share
-
-
-
-
Interest and investment income
149,39 млн
1,36 млд
72,42 млн
13,58 млн
Interest expense
-156,33 млн
-1,34 млд
-266,58 млн
-301,05 млн
Net interest expenses
-6,94 млн
19,56 млн
-194,16 млн
-287,47 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
11,71 млд
2,63 млд
5,73 млд
7,38 млд
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google колдонмолору